DANSKE BANK A/S (DSN.DE) Fundamental Analysis & Valuation

FRA:DSN • DK0010274414

Current stock price

42.64 EUR
-0.3 (-0.7%)
Last:

This DSN.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. DSN.DE Profitability Analysis

1.1 Basic Checks

  • DSN had positive earnings in the past year.
  • DSN had a positive operating cash flow in the past year.
  • Of the past 5 years DSN 4 years were profitable.
  • In multiple years DSN reported negative operating cash flow during the last 5 years.
DSN.DE Yearly Net Income VS EBIT VS OCF VS FCFDSN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100B -100B

1.2 Ratios

  • With a Return On Assets value of 0.61%, DSN is not doing good in the industry: 60.38% of the companies in the same industry are doing better.
  • DSN's Return On Equity of 12.72% is fine compared to the rest of the industry. DSN outperforms 61.32% of its industry peers.
Industry RankSector Rank
ROA 0.61%
ROE 12.72%
ROIC N/A
ROA(3y)0.61%
ROA(5y)0.4%
ROE(3y)12.75%
ROE(5y)8.48%
ROIC(3y)N/A
ROIC(5y)N/A
DSN.DE Yearly ROA, ROE, ROICDSN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10

1.3 Margins

  • DSN has a Profit Margin (23.53%) which is in line with its industry peers.
  • In the last couple of years the Profit Margin of DSN has grown nicely.
  • DSN does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 23.53%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-35.59%
PM growth 5Y45.78%
GM growth 3YN/A
GM growth 5YN/A
DSN.DE Yearly Profit, Operating, Gross MarginsDSN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

1

2. DSN.DE Health Analysis

2.1 Basic Checks

  • DSN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for DSN has been reduced compared to 1 year ago.
  • The number of shares outstanding for DSN has been reduced compared to 5 years ago.
  • Compared to 1 year ago, DSN has a worse debt to assets ratio.
DSN.DE Yearly Shares OutstandingDSN.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
DSN.DE Yearly Total Debt VS Total AssetsDSN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1T 2T 3T 4T

2.2 Solvency

  • The Debt to FCF ratio of DSN is 55.17, which is on the high side as it means it would take DSN, 55.17 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 55.17, DSN is in line with its industry, outperforming 54.72% of the companies in the same industry.
  • DSN has a Debt/Equity ratio of 6.26. This is a high value indicating a heavy dependency on external financing.
  • DSN has a Debt to Equity ratio of 6.26. This is amonst the worse of the industry: DSN underperforms 94.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.26
Debt/FCF 55.17
Altman-Z N/A
ROIC/WACCN/A
WACC4.03%
DSN.DE Yearly LT Debt VS Equity VS FCFDSN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200B 400B 600B 800B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
DSN.DE Yearly Current Assets VS Current LiabilitesDSN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100B 200B 300B 400B 500B

3

3. DSN.DE Growth Analysis

3.1 Past

  • DSN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.72%.
  • Measured over the past years, DSN shows a very strong growth in Earnings Per Share. The EPS has been growing by 42.79% on average per year.
  • DSN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.60%.
  • The Revenue has been decreasing by -2.83% on average over the past years.
EPS 1Y (TTM)0.72%
EPS 3YN/A
EPS 5Y42.79%
EPS Q2Q%8.45%
Revenue 1Y (TTM)-10.6%
Revenue growth 3YN/A
Revenue growth 5Y-2.83%
Sales Q2Q%-38.58%

3.2 Future

  • The Earnings Per Share is expected to grow by 5.51% on average over the next years.
  • The Revenue is expected to grow by 3.11% on average over the next years.
EPS Next Y4.31%
EPS Next 2Y5.09%
EPS Next 3Y5.51%
EPS Next 5YN/A
Revenue Next Year3.46%
Revenue Next 2Y3.21%
Revenue Next 3Y3.11%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DSN.DE Yearly Revenue VS EstimatesDSN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 20B 40B 60B 80B 100B
DSN.DE Yearly EPS VS EstimatesDSN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 10 20 30

4

4. DSN.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • DSN is valuated reasonably with a Price/Earnings ratio of 11.43.
  • DSN's Price/Earnings ratio is in line with the industry average.
  • DSN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.91.
  • With a Price/Forward Earnings ratio of 10.95, the valuation of DSN can be described as very reasonable.
  • The rest of the industry has a similar Price/Forward Earnings ratio as DSN.
  • DSN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.69.
Industry RankSector Rank
PE 11.43
Fwd PE 10.95
DSN.DE Price Earnings VS Forward Price EarningsDSN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 62.26% of the companies in the same industry are more expensive than DSN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 12.95
EV/EBITDA N/A
DSN.DE Per share dataDSN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.65
PEG (5Y)0.27
EPS Next 2Y5.09%
EPS Next 3Y5.51%

6

5. DSN.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 7.54%, DSN is a good candidate for dividend investing.
  • DSN's Dividend Yield is rather good when compared to the industry average which is at 4.88. DSN pays more dividend than 88.68% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, DSN pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.54%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
DSN.DE Yearly Dividends per shareDSN.DE Yearly Dividends per shareYearly Dividends per share 2026 5 10 15

5.3 Sustainability

  • DSN pays out 53.11% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP53.11%
EPS Next 2Y5.09%
EPS Next 3Y5.51%
DSN.DE Yearly Income VS Free CF VS DividendDSN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100B -100B
DSN.DE Dividend Payout.DSN.DE Dividend Payout, showing the Payout Ratio.DSN.DE Dividend Payout.PayoutRetained Earnings

DSN.DE Fundamentals: All Metrics, Ratios and Statistics

DANSKE BANK A/S

FRA:DSN (4/8/2026, 7:00:00 PM)

42.64

-0.3 (-0.7%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)02-05
Earnings (Next)04-30
Inst Owners27.83%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap35.60B
Revenue(TTM)97.93B
Net Income(TTM)23.04B
Analysts71.67
Price Target47.42 (11.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.54%
Yearly Dividend1.99
Dividend Growth(5Y)N/A
DP53.11%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.69%
Min EPS beat(2)1.08%
Max EPS beat(2)8.31%
EPS beat(4)3
Avg EPS beat(4)3.39%
Min EPS beat(4)-0.66%
Max EPS beat(4)8.31%
EPS beat(8)7
Avg EPS beat(8)5.01%
EPS beat(12)10
Avg EPS beat(12)4.34%
EPS beat(16)11
Avg EPS beat(16)-59.67%
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-1.51%
Max Revenue beat(2)2.24%
Revenue beat(4)2
Avg Revenue beat(4)3.92%
Min Revenue beat(4)-1.51%
Max Revenue beat(4)15.52%
Revenue beat(8)6
Avg Revenue beat(8)49.18%
Revenue beat(12)10
Avg Revenue beat(12)64.42%
Revenue beat(16)14
Avg Revenue beat(16)63.41%
PT rev (1m)0%
PT rev (3m)21%
EPS NQ rev (1m)-0.8%
EPS NQ rev (3m)5.44%
EPS NY rev (1m)0%
EPS NY rev (3m)2.14%
Revenue NQ rev (1m)-1.04%
Revenue NQ rev (3m)0.65%
Revenue NY rev (1m)0.78%
Revenue NY rev (3m)1.61%
Valuation
Industry RankSector Rank
PE 11.43
Fwd PE 10.95
P/S 2.72
P/FCF 12.95
P/OCF 11.8
P/B 1.47
P/tB 1.54
EV/EBITDA N/A
EPS(TTM)3.73
EY8.75%
EPS(NY)3.89
Fwd EY9.13%
FCF(TTM)3.29
FCFY7.72%
OCF(TTM)3.61
OCFY8.48%
SpS15.69
BVpS29.03
TBVpS27.77
PEG (NY)2.65
PEG (5Y)0.27
Graham Number49.36
Profitability
Industry RankSector Rank
ROA 0.61%
ROE 12.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 23.53%
GM N/A
FCFM 20.99%
ROA(3y)0.61%
ROA(5y)0.4%
ROE(3y)12.75%
ROE(5y)8.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-35.59%
PM growth 5Y45.78%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 6.26
Debt/FCF 55.17
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 2.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 89.2%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC4.03%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1.93%
Cap/Sales(5y)7.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.72%
EPS 3YN/A
EPS 5Y42.79%
EPS Q2Q%8.45%
EPS Next Y4.31%
EPS Next 2Y5.09%
EPS Next 3Y5.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.6%
Revenue growth 3YN/A
Revenue growth 5Y-2.83%
Sales Q2Q%-38.58%
Revenue Next Year3.46%
Revenue Next 2Y3.21%
Revenue Next 3Y3.11%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y121.69%
FCF growth 3YN/A
FCF growth 5Y-35.58%
OCF growth 1Y124.39%
OCF growth 3YN/A
OCF growth 5Y-34.46%

DANSKE BANK A/S / DSN.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DANSKE BANK A/S?

ChartMill assigns a fundamental rating of 3 / 10 to DSN.DE.


What is the valuation status for DSN stock?

ChartMill assigns a valuation rating of 4 / 10 to DANSKE BANK A/S (DSN.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for DANSKE BANK A/S?

DANSKE BANK A/S (DSN.DE) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for DSN stock?

The Price/Earnings (PE) ratio for DANSKE BANK A/S (DSN.DE) is 11.43 and the Price/Book (PB) ratio is 1.47.


How financially healthy is DANSKE BANK A/S?

The financial health rating of DANSKE BANK A/S (DSN.DE) is 1 / 10.